New Cell Type Discovered in Human Brains
Researchers have discovered a new type of inhibitory neuron present in human, but not mouse, brains. So-called rosehip neurons, described yesterday (August 27) in Nature
Researchers have discovered a new type of inhibitory neuron present in human, but not mouse, brains. So-called rosehip neurons, described yesterday (August 27) in Nature
The European Commission has approved the use of Novartis’s tisagenlecleucel (Kymriah) and Gilead’s axicabtagene ciloleucel (Yescarta), two chimeric antigen receptor T cell (CAR T) therapies,
Ultrasound and microbubbles can safely open the blood-brain barrier in patients with Alzheimer’s disease, researchers reported yesterday (July 25) in Nature Communications and at the
An Alzheimer’s drug slows the rate of cognitive decline while reducing the amount of plaques in patients’ brains, according to the results of a clinical
CRISPR gene editing can create large numbers of unwanted DNA changes that may go undetected, researchers report today (July 16) in Nature Biotechnology. The findings
Opioids—one of the most effective treatments for pain—come with a host of potential side effects: addiction, risk of overdose, and the development of tolerance that
Injecting human cardiac muscle cells into monkeys that suffered heart attacks helped the animals’ damaged hearts pump blood better, researchers report July 2 in Nature
CAR-T therapies—genetically engineered T cells that destroy cancer cells—have proven to be promising options when other treatments fail. However, there’s currently no one-size-fits-all CAR T,
If youngsters told their elders to be quiet, stress levels would surely rise. But, when it comes to brain cells, it seems the opposite is
Researchers used magnetically driven microrobots to carry cells to predetermined spots within living zebrafish and mice, they report in Science Robotics today (June 27). The
Agenetically modified poliovirus given to patients with recurrent glioblastoma—an advanced form of brain cancer—appears to lengthen survival times, researchers reported today (June 26) in the
Agenetically modified poliovirus given to patients with recurrent glioblastoma—an advanced form of brain cancer—appears to lengthen survival times, researchers reported today (June 26) in the
Agenetically modified poliovirus given to patients with recurrent glioblastoma—an advanced form of brain cancer—appears to lengthen survival times, researchers reported today (June 26) in the
Designer bugs as drugs The endemic persistence and outbreaks of Vibrio cholerae indicate a need for new methods of control; in this issue, two groups
An analysis of more than 30 years of research has revealed the underlying cause of the most common form of leukemia in children. Research compiled
Due to advances in rare-disease research and individualized cell and gene therapies, there has been a recent crop of treatments approved by regulatory agencies not
Created by ePubSystems. Contact Us for similar site for your university or institute.